CareDx, Inc. (CDNA) Dividend History

CareDx, Inc. (CDNA) is a molecular diagnostics company specializing in transplantation testing and monitoring. It develops and commercializes proprietary diagnostic products to improve graft survival and patient outcomes for organ transplant recipients. The company's offerings include assays for immune system monitoring and early detection of organ rejection, primarily serving the transplant community.

8000 Marina Blvd, Brisbane, CA, 94005
Phone: 415-287-2300
Website: https://www.caredx.com

Dividend History

CareDx, Inc. currently does not pay dividends

Company News

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

Johnson Fistel, a law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws. The investigation is related to CareDx's issuance of false and misleading public statements regarding its compliance with healthcare laws and revenue growth, which led to a significant drop in the company's stock price.

GlobeNewswire Inc.
ALERTA PARA LOS ACCIONISTAS: Morris Kandinov investiga a CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., y Tax Free Fund for Puerto Rico Residents, Inc.; se anima a los accionistas a ponerse en contacto con la firma

The law firm Morris Kandinov is investigating several companies, including CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc., for potential breaches of fiduciary duties and other legal violations on behalf of shareholders.

GlobeNewswire Inc.
SHAREHOLDER ALERT: Morris Kandinov Investigating CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc.; Shareholders are Encouraged to Contact the Firm

Morris Kandinov, a national law firm, is investigating potential breaches of fiduciary duties and other legal violations by CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc. Shareholders are encouraged to contact the firm to learn more about their rights.

GlobeNewswire Inc.
Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights

The liquid biopsy market is experiencing significant growth, driven by advancements in technology and increasing demand for non-invasive diagnostic methods. North America is the largest market, with a 48.11% share in 2023. Key drivers include increased benefits over conventional biopsy, rising cancer incidence, and technological advancements, while high costs and shortage of skilled professionals pose challenges.

GlobeNewswire Inc.

Featured Companies: BIO BIO.B EXAS GH ILMN MDXH MYGN NTRA QGEN TMO
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024

This report analyzes the global market for laboratory-developed tests (LDTs), including the impact of new FDA regulations introduced in 2024. It covers the LDT services market and the market for LDT products sold to clinical laboratories, with a focus on key segments like infectious disease and oncology.

GlobeNewswire Inc.

Featured Companies: A ADPT BDSX BRKR DGX GH ILMN LH MDXH MYGN NEO NTRA OPK PACB PKI QGEN TMO WAT

Dividend data last updated 06/07/2025 20:37:03 UTC